Position in CLDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,233,500
-$35,303,159 QoQ
Shares Held
1,350,000
-49.9% QoQ
Ownership
1.72%
of shares outstanding
% of Portfolio
3.01%
of 13F equity value
Holder Rank
#13
of 252 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Commodore Capital LP holds $1,375,688,495 across 28 Biotechnology names. CLDX ranks #11 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLAY |
Relay Therapeutics, Inc.
|
12,000,000 | $224,520,000 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
3,275,000 | $166,206,250 | |
| 3 | COGT |
Cogent Biosciences, Inc.
|
3,050,000 | $118,035,000 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
2,000,000 | $94,080,000 | |
| 5 | SYRE |
Spyre Therapeutics, Inc.
|
846,786 | $75,177,661 | |
| 6 | ANRO |
Alto Neuroscience, Inc.
|
2,723,196 | $71,865,142 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
2,250,000 | $70,335,000 | |
| 8 | EYPT |
EyePoint, Inc.
|
4,600,000 | $65,780,000 |
All Filings in CLDX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,233,500 | 1,350,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $85,536,659 | 2,696,616 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $69,665,400 | 2,565,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $78,343,026 | 3,028,335 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $70,207,500 | 3,450,000 | Shares | Sole | 2025-08-14 | |
| 2025-04-03 | $57,452,500 | 3,350,000 | Shares | Sole | 2025-04-10 | |
| 2025-03-31 | $58,080,000 | 3,200,000 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $55,027,668 | 1,618,937 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $52,739,250 | 1,425,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $36,365,661 | 866,468 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $27,840,011 | 701,967 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $19,447,420 | 706,665 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $21,432,393 | 631,665 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,839,711 | 495,823 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $22,098,831 | 495,823 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $15,146,005 | 538,812 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,526,371 | 538,812 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,215,237 | 241,199 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $13,400,695 | 248,207 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $10,815,733 | 323,437 | Shares | Sole | 2021-10-14 | |
| 2021-03-31 | $7,620,990 | 369,951 | Shares | Sole | 2021-10-14 | |
| 2020-12-31 | $6,244,671 | 356,431 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||